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Abstract
NK cells are important immune effectors for preventing microbial invasion and dissemination, through natural cytotoxicity
and cytokine secretion. Bacillus anthracis spores can efficiently drive IFN-c production by NK cells. The present study
provides insights into the mechanisms of cytokine and cellular signaling that underlie the process of NK-cell activation by B.
anthracis and the bacterial strategies to subvert and evade this response. Infection with non-toxigenic encapsulated B.
anthracis induced recruitment of NK cells and macrophages into the mouse draining lymph node. Production of edema (ET)
or lethal (LT) toxin during infection impaired this cellular recruitment. NK cell depletion led to accelerated systemic bacterial
dissemination. IFN-c production by NK cells in response to B. anthracis spores was: i) contact-dependent through RAE-1-
NKG2D interaction with macrophages; ii) IL-12, IL-18, and IL-15-dependent, where IL-12 played a key role and regulated
both NK cell and macrophage activation; and iii) required IL-18 for only an initial short time window. B. anthracis toxins
subverted both NK cell essential functions. ET and LT disrupted IFN-c production through different mechanisms. LT acted
both on macrophages and NK cells, whereas ET mainly affected macrophages and did not alter NK cell capacity of IFN-c
secretion. In contrast, ET and LT inhibited the natural cytotoxicity function of NK cells, both in vitro and in vivo. The
subverting action of ET thus led to dissociation in NK cell function and blocked natural cytotoxicity without affecting IFN-c
secretion. The high efficiency of this process stresses the impact that this toxin may exert in anthrax pathogenesis, and
highlights a potential usefulness for controlling excessive cytotoxic responses in immunopathological diseases. Our findings
therefore exemplify the delicate balance between bacterial stimulation and evasion strategies. This highlights the potential
implication of the crosstalk between host innate defences and B. anthracis in initial anthrax control mechanisms.
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Introduction
NK cells are immune cells that do not need prior exposure to
antigen to exert their functions. Their receptors are germline
encoded and do not require somatic gene rearrangements. These
receptors recognise an array of self-molecules through highly
specific mechanisms. The functions of NK cells are regulated
through a delicate balance between activating and inhibitory
receptors. Although NK cells are traditionally considered as
belonging to the innate immune system, a number of recent
reports have shown that NK cell education can occur, leading to
an expansion of pathogen-specific cells and generation of
‘memory’ cells [1]. NK cells perform a surveillance task and react
to transformed, stressed, and virally infected cells. They represent
a first-line of defence against cancer and pathogen invasion.
NK cells are important immune effectors for preventing
microbial invasion and dissemination [1]. They are found in
blood as well as in peripheral nonlymphoid tissues and secondary
lymphoid organs [1]. In early host responses, NK cells exert two
principal functions: secretion of a range of cytokines and natural
cytotoxicity. Among secreted cytokines, IFN-c plays a key role in
enhancing immune responses, in particular by modulating
macrophage activation [2]. NK-cell activation is readily induced
during viral and bacterial infections and requires cytokine and
receptor signals that are delivered by myeloid cells [3–5], such as
IFN-a/b [6], IL-12 [7], IL-15 [6] and IL-18 [8]. Apart from a
potential role in polymicrobial sepsis [9], NK-cell implication
during bacterial infections has been studied in few models, mainly
of intracellular bacteria (Mycobacterium sp., Listeria monocytogenes,
Salmonella enterica serovar Typhimurium) [5]. Among the extracellular
bacteria, Staphylococcus aureus and the anaerobe Lactobacillus johnsonii
have been reported to stimulate NK cells [5].
Spores of the extracellular bacterial pathogen Bacillus anthracis
can efficiently drive IFN-c production in large amounts by NK
PLoS Pathogens | www.plospathogens.org 1 January 2012 | Volume 8 | Issue 1 | e1002481cells [10]. The spore is the infectious bacterial form that first
interacts with the host, thereby eliciting the earliest host defences
against infection. The innate immune response was originally
considered as a non-specific response characterized by engulfment
and digestion of microorganisms and foreign substances by
phagocytic cells. However, innate immunity does show consider-
able specificity through the activation of different signaling
pathways associated with different Toll-like receptors (TLRs) that
recognise different pathogen-associated molecular patterns. Acti-
vation of TLRs thus results in different biological responses
depending on the pathogen. NK cell activation induced by the B.
anthracis spore is independent of TLR2, TLR4, and TLR7 [10]
and is probably dependent on multiple receptor engagement due
to the complex nature of the spore. The downstream signaling
pathways nevertheless implicate the adaptor molecule MyD88
[10]. Among the primary effector cells of innate immunity to
intervene at the portal of B. anthracis entry, macrophages have been
implicated in two contrasting processes: (i) the initiation of
infection by playing a role in spore germination [11] and spore
dissemination [12], and (ii) the control of infection through spore
phagocytosis and destruction [11,13,14]. Neutrophils are recruited
in the first hours of infection and are involved in the early control
of infection [14,15]. Lung dendritic cells (DCs) play a pivotal role
in spore uptake and promote dissemination of spores from the
alveolar space into the draining lymph nodes [14].
Many of the symptoms of systemic anthrax can be attributed to
the subversive effects of a poly-c-D-glutamic capsule and toxins.
Anthrax toxins suppress the immune defences of the host by
targeting cells of innate and adaptive immunity. B. anthracis thus
completely evades almost all of the key players responsible for
efficient host protection. B. anthracis toxins are made up of three
secreted proteins, protective antigen (PA), edema factor (EF; a
calmodulin-dependent adenylate cyclase that increases intracellu-
lar concentrations of cAMP in host cells [16]) and lethal factor (LF;
a zinc-dependent metalloprotease which cleaves the N-terminal
region of mitogen-activated protein kinase kinases [MAPKKs]
[17]). Functionally, the combination of PA with EF or LF forms
edema toxin (ET) or lethal toxin (LT) respectively [18,19]. LT kills
or inactivates monocytes, macrophages, and neutrophils [14]
whereas ET disrupts cytokine networks in monocytes [14], and
reduces macrophage migration [14]. Both LT and ET impair
neutrophil actin-based motility, resulting in paralysis of PMN
chemotaxis [14,20]. Anthrax toxins impair activation and
maturation of DCs, thus blocking the initiation of adaptive
immunity [21,22]. LT disrupts TCR signaling in CD1d-restricted
NKT cells, leading to functional unresponsiveness [23]. LT also
severely reduces B-cell proliferation, impairs immunoglobulin
production [24], and blocks MAPKK-dependent cytokine pro-
duction in CD4+ T cells [25,26]. Furthermore, ET reduces T-cell
migration [14] and disrupts T-cell function [14]. Anthrax toxins
are therefore involved in mediating immune evasion of the
bacterium by interfering with the innate and adaptive immune
responses.
NK cells are pivotal in the first-line of innate defence, serving as
a functional bridge between innate and acquired immunity. To
our knowledge, their role during B. anthracis infection has yet to be
addressed. The present study aimed to characterise the mecha-
nisms of NK-cell activation by B. anthracis spores, the strategies
employed by the bacteria to subvert and evade this response
through toxin secretion. We also aimed to identify the relevance of
these processes for controlling B. anthracis infection. Relatively few
studies have linked specific cytokines with protection against B.
anthracis. However, IFN-c increases the ability of macrophages to
resist destruction by B. anthracis and to kill the bacteria [27] and we
have shown that sensitivity to B. anthracis infection was partially
dependent on IFN-c [28]. As NK cells are the main innate
immune cells to produce IFN-c, we focused our study on these
novel cellular targets of anthrax toxins in the context of the
complex heterocellular interactions induced by B. anthracis spores.
Results
B. anthracis spores activate NK cells through accessory-
cell- and contact-dependent interactions
B. anthracis spores induce naive spleen cells to secrete large
amounts of IFN-c. This phenomenon depends upon the
interactions between CD49b
+ cells and accessory cells from the
CD49b-negative fraction (Figure 1A). Depletion of CD49b
+ cells
led to a significant 6.5-fold decrease of IFN-c production
(Figure 1A). Direct stimulation of purified CD49b
+ cells with
spores did not induce IFN-c secretion. However, co-culture of
positively selected CD49b cells with CD49b-negative splenocytes
restored IFN-c production upon spore stimulation (Figure 1A).
As our study was focused on spore components as the initial
stimuli of the innate immune system, spores needed to be
inactivated and prevented from germinating and developing into
vegetative bacilli. Different means of inactivation (i.e. heat-
inactivation, germination-deficient spores, and live spores in the
presence of antibiotics) did not modify the extent of IFN-c
induction when compared with formaldehyde inactivation
(Figure 1B). Spores of the phylogenetically distant B. subtilis gave
rise only to a modest IFN-c production, demonstrating that B.
anthracis spore components are more efficient in inducing IFN-c
production than those of B. subtilis. Latex beads of comparable size
as B. anthracis spores were ineffective in stimulating IFN-c secretion
by splenocytes, indicating that phagocytosis of inert particles alone
was not sufficient and that B. anthracis spores were central for this
response.
Similarly, stimulation with spores of positively selected CD49b
cells with bone-marrow derived macrophages (BMDMs) resulted
in a strong induction of IFN-c secretion (Figure 1C) and activation
Author Summary
NK cells are important immune effectors that perform a
surveillance task and react to transformed, stressed, and
virally infected cells. They represent a first-line defence
against cancer and pathogen invasion. Different patho-
gens trigger distinct NK-cell activation pathways. The
Bacillus anthracis spore is the highly resistant form that
enters the host and provokes anthrax. This microbe kills
through a combination of acute bacterial infection and
devastating toxemia. In the present study, we characterise
the crosstalk between NK cells and spores, as well as the
strategies used by B. anthracis to evade initial control
mechanisms and impact anthrax pathogenesis. Our
findings exemplify the spores’ property to efficiently drive
a high production of IFN-c by NK cells, as well as the
complex pathways used for activation which require both
cytokine and cellular signaling. B. anthracis subverts this
response through its toxins by paralysing essential NK cell
functions. Furthermore, edema toxin from B. anthracis
blocks natural cytotoxicity without affecting IFN-c secre-
tion. The CyaA toxin of Bordetella pertussis possesses the
same enzymatic activity and has a similar effect. The high
efficiency of these toxins in blocking cytotoxicity in vivo
implies possible exploitation of their subverting activity to
modulate excessive cytotoxic responses in immunopath-
ological diseases.
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+ cells (Figure 1D); i.e. a 7.3-fold upregulation of the
leukocyte early activation marker CD69 and a 32-fold increase of
intracellular IFN-c positive cells (Figure 1D and S1A). Stimulation
of isolated CD49b
+ cells or BMDMs by spores did not result in
IFN-c secretion (Figure 1C), nor did it change basal expression of
CD69 or intracellular IFN-c (Figure 1D). IFN-c secretion by
CD49b
+ cells from NKT-deficient CD1d
2/2 mice [29,30] was
similar to that by CD49b
+ wild-type cells when co-cultured with
Figure 1. Contact dependence of NK cell activation by B. anthracis spores. C57BL/6 splenocytes, either unsorted (A and B), fractionated with
anti-CD49b magnetic beads (A), or purified CD49b
+ spleen cells cocultured with BMDMs (C) were stimulated with formaldehyde-inactivated spores
(FIS), or (B) with heat-inactivated spores (HKS), live spores in the presence of antibiotics, a germination-deficient strain, formaldehyde-inactivated
B.subtilis spores or latex beads; (C) the NKG2D receptor was neutralized, or the CD49b
+ cells and BMDMs were separated in a Transwell system. IFN-c
concentrations were determined in the supernatants by ELISA as described in Materials and Methods. Results shown are the mean 6 SD for triplicate
cultures representative of at least three experiments. (D) FACS analysis of surface CD69 and intracellular IFN-c expression in spore-stimulated CD49b
+
cells in the presence of BMDMs (see Figure S1A for gating strategy and controls); percentage for each positive cell population shown in the upper
right quadrant of each dot plot; data representative of three independent experiments; the mean fold increase was 8.460.7 and 12.465 for CD69 and
IFN-c expression respectively; (E) CD49b
+ cells from NKT-deficient CD1d
2/2 mice stimulated with FIS in the presence of BMDMs from WT C57BL/6
mice produce similar amounts of IFN-c than WT C57BL/6 mice; (F) same experimental conditions as in (C) with neutralization of NKG2D and/or RAE-1.
(G) FACS analysis of RAE-1 surface expression on FIS-stimulated BMDMs and effect of incubation with ET and LT; mean fluorescence intensity of the
positive peak (upper left corner) and percentage of the positive cell population are shown in each dot plot. Isotype-matched controls Abs were used
for each staining combination (filled histogram). Data are representative of at least three independent experiments giving similar results. Significant
differences between experimental conditions are indicated with asterisks (t test; *, P,0.05; **, P,0.01).
doi:10.1371/journal.ppat.1002481.g001
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suggests that NK cells were the main source of IFN-c production
in this bacterial system.
NK-cell activity is regulated by both contact-dependent and
soluble signals. Direct contact between BMDMs and NK cells was
necessary for NK cell activation as: (i) conditioned medium from
spore-stimulated BMDMs did not elicit IFN-c secretion
(Figure 1C); and (ii) physical separation of purified NK cells and
BMDMs in compartments of transwell plates did not lead to IFN-c
secretion, even if stimulation with the spores was effected in both
compartments (Figure 1C). The activating receptor, NKG2D,
elicits cytokine production by NK cells [31,32]. The present study
also implicated the NKG2D receptor in the interaction between
NK cells and spore-stimulated BMDMs as addition of neutralizing
antibody for the NKG2D receptor decreased IFN-c production
(Figure 1C and 1F). Similarly, neutralizing antibody for RAE-1 —
one of the NKG2D ligands— partially inhibited IFN-c production
and co-neutralization of NKG2D and RAE-1 led to a greater
reduction (Figure 1F). Finally, stimulation of BMDMs with B.
anthracis spores resulted in an approximately 19-fold upregulation
of RAE-1 expression compared with non-stimulated BMDMs
(Figure 1G). The activating receptor NKp46 was not involved as
its neutralization did not modify IFN-c secretion induced by
spores (Figure S1B).
Taken together, these results indicate that NK cell activation
and IFN-c production in response to B. anthracis spores are
dependent on an accessory cell, are contact-dependent, and occur
through RAE-1-NKG2D interaction.
Functional relationship between IL-12 and IL-18 during
stimulation by B. anthracis spores
Stimulation of BMDMs with B. anthracis spores induced
secretion of IL-12 (Figure 2A). Neutralization of IL-18 or blocking
the IL-15Ra receptor did not alter IL-12 secretion. Macrophage-
secreted IL-12 appeared to play a key role in NK-cell activation by
B. anthracis spores as: (i) IL-12 neutralizing antibodies abolished
IFN-c secretion both in splenocytes and co-cultured BMDMs/
purified NK cells (Figure 2B), and (ii) stimulation of splenocytes
from IL-12
2/2 and IL-12 R
2/2 mice did not elicit IFN-c
production (Figure 2C). Furthermore, absence of IL-12 secretion
by spore-stimulated BMDMs from IL-12
2/2 mice did not induce
IFN-c secretion by wild-type NK cells (Figure 2D).
However, NK cells from IL-12R
2/2 mice were weakly
activated by spore-stimulated wild-type BMDMs (Figure 2E),
indicating that other signals besides IL-12 were able to activate
NK cells. This low amount of IFN-c production was completely
abolished by the addition of neutralizing antibody for IL-18
(Figure 2E). Thus, in the absence of IL-12 signaling, IL-18
becomes essential for the induction of IFN-c. This was
experimentally confirmed by the addition of IL-18 neutralizing
antibodies, which significantly decreased spore-induced IFN-c
production by wild-type splenocytes or co-cultured BMDMs and
purified NK cells (Figure 2B). Expression of the IL-12 receptor by
BMDMs was also important for full NK cell activation in response
to spores; IFN-c production by wild-type NK was significantly
lower with spore-stimulated BMDMs from IL-12R
2/2 mice
compared with their wild-type counterparts (Figure 2D). This
finding implies a positive feedback of IL-12 and its important role
in influencing the stimulatory capacities of macrophages.
Blocking the IL-15Ra receptor led to a partial but significant
inhibition of IFN-c production in both spore-stimulated spleno-
cytes and purified NK cells co-cultured with BMDMs (Figure 2B).
Finally, simultaneous neutralization of IL-18 and IL-15 strongly
decreased IFN-c production (Figure 2B). This indicates that IL-12-
induced IFN-c production depends upon IL-18 and IL-15 and
suggests a synergistic mechanism of action of IL-12 with IL-18
and/or IL-15. As mentioned above, inhibition of IFN-c
production by IL-18 or/and IL-15 neutralizing antibodies was
not associated with a decrease in IL-12 secretion (Figure 2A). The
hypothesis that IL-18 or IL-15 are necessary for optimal IL-12
secretion by spore-stimulated BMDMs can therefore be excluded.
Of the other cytokines tested, TNF-a, IFN-a, IFN-b, and IL-10
were not involved in the stimulation of IFN-c secretion, as their
neutralization did not interfere with IFN-c secretion (Figure S1B).
IL-18 is stored in internal cellular compartments as a precursor
and can rapidly be secreted through caspase-1 activation whereas
IL-12 needs to be synthesized before secretion. To explore
whether IL-18 is secreted earlier than IL-12 in spore-induced
macrophage activation and NK cell IFN-c production, we
determined whether short-term priming with IL-18 or IL-12 was
sufficient to achieve full activation of NK cells during stimulation
with B. anthracis spores. A 4-h priming of splenocytes with IL-18
before spore stimulation followed by neutralization of IL-18 for the
remaining incubation period with spores was sufficient to reach
similar concentrations of IFN-c to those obtained in the absence of
IL-18 neutralization. In contrast, IL-18 neutralization for the
entire length of spore-incubation significantly decreased IFN-c
production (Figure 2F). However, similar short-term priming with
IL-12, followed by neutralization of IL-12 for the remaining
incubation period with spores, only partially restored the IFN-c
response compared with spore-incubation without IL-12 neutral-
ization (Figure 2F). Thus B. anthracis spores induce IL-18 signaling
as a primary event that probably synergizes with IL-12 signaling
which needs to be effective for a longer period to activate IFN-c
secretion by NK cells. Both IL-12 and IL-18 are therefore essential
for IFN-c production by NK cells in response to B. anthracis spores.
Spore recognition by macrophages triggers downstream signal-
ing pathways that are dependent on MyD88, an adapter protein
essential not only for the induction of inflammatory cytokines
triggered by TLRs, but also for signaling downstream to IL-18 and
IL-1 receptors. Splenocytes from MyD88-deficient mice cannot
produce IFN-c in response to B. anthracis spores [10]. To identify
the cells on which the MyD88 adapter protein is required, we
performed mixed experiments co-culturing macrophages and NK
cells from WT or MyD88-deficient mice. NK cells deficient in
MyD88 did not produce IFN-c; this is most likely due to the defect
in IL-18 downstream signaling as IL-18 is central in this system of
NK cell activation (Figure 2G). Macrophages from MyD88-
deficient mice were also impaired in their capacity to help NK cells
to produce IFN-c following spore stimulation. IL-12 production
was strongly decreased (Figure 2H, left panel), thus inhibiting IFN-
c production (Figure 2H, right panel). These results demonstrate
that MyD88 is implicated both in the macrophage —through
recognition of B. anthracis spores by yet to be characterised
pathogen pattern-based receptors— and in the NK cells —
through activation of the IL-18 signaling pathway.
Dissociation of NK cell functions by ET versus global
inhibition by LT
As B. anthracis toxins secreted by the nascent bacilli upon spore
germination could subvert the innate immune response to spores
at the initial step of infection, the effects of toxins on spore-induced
IFN-c production were evaluated.
The toxins interfered with contact-dependent signaling, as the
spore-induced increase in RAE-1 expression on BMDMs was
efficiently downregulated by ET or LT-treatment (Figure 1G).
The toxins also impaired cytokine-dependent signaling. LT
disrupted the ability of splenocytes stimulated with B. anthracis
NK Cell- B. anthracis Crosstalk
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manner (Figure 3A and 3B); doses as low as 1 ng/ml and 0.1 ng/
ml, respectively, significantly inhibited IL-12 and IFN-c secretion.
The addition of IL-12 or IL-18 did not restore LT-inhibited IFN-c
secretion (Figure 3C). Cell viability was unaffected (Figure S1C).
These results suggest that LT blocks the NK cell response to IFN-c
inducing stimuli by interfering with IL-12 and IL-18 signaling.
To explore the direct effects of LT on NK cells and the
mechanisms of inhibition of IFN-c production by LT, purified NK
cells were co-stimulated with IL-12 and IL-18 in the absence of
accessory cells. As expected [33], this resulted in abundant IFN-c
production (Figure 4A and 4B; PA only) and rapid phosphoryla-
tion of p38, ERK1/2, and JNK MAPK (Figure 4C). IFN-c
secretion by IL-12/IL-18-stimulated purified NK cells was totally
inhibited with LT in a dose-dependent manner (Figure 4A);
statistically significant inhibition was observed from doses as low as
1 ng/ml in these conditions of strong stimulation. LT inhibited
p38, ERK1/2, and JNK MAPK phosphorylation (Figure 4C). The
viability of NK cells was unaffected by LT treatment, even at the
highest dose of 100 ng/ml over the 18 h culture period
(Figure 4D). Assessment of metabolic activity using the MTS
assay (which measures the activity of mitochondrial deshydro-
Figure 2. Network of cytokine dependence of NK cell activation by B. anthracis spores. Effect of neutralization of IL-12, IL-18 or IL-15Ra on
(A) IL-12p40/p70 concentration in culture supernatants of FIS-stimulated BMDMs or (B) IFN-c production by splenocytes (SPL; left panel), or purified
CD49b
+ cells co-cultured with BMDMs (right panel). (C) Splenocytes (SPL) from wild-type (WT), IL-12R
2/2 or IL-12
2/2 C57BL/6 mice were stimulated
with FIS, or ConA as a positive control. (D) CD49b
+ cells from WT C57BL/6 mice were co-cultured with BMDMs from IL-12R
2/2 or IL-12
2/2 C57BL/6
mice in the presence of FIS. (E) CD49b
+ cells from WT or IL-12R
2/2 C57BL/6 mice were co-cultured with BMDMs from WT C57BL/6 mice in the
presence of FIS with or without IL-18 neutralizing antibody. (F) Effect of short-term priming with IL-12 or IL-18 on spore-stimulation of splenocytes;
corresponding cytokine neutralization was maintained for the remainder of the assay. (G) Purified CD49b
+ cells from WT or MyD88
2/2 C57BL/6 mice
were co-cultured with BMDMs from WT C57BL/6 in the presence of FIS. (H) Purified CD49b
+ cells from C57BL/6 WT mice were co-cultured with
BMDMs from WT or MyD88
2/2 C57BL/6 mice in the presence of FIS; IL-12 (left panel), or IFN-c (right panel) production. For all experiments with
purified CD49b
+ cells, no IFN-c was detected after direct stimulation with spores (D, E, G, H; data not shown). For all experiments, values are mean 6
SD for at least three measurements and are representative of at least three independent experiments. Significant differences between experimental
conditions are indicated with asterisks (t test; *, P,0.05; **, P,0.01).
doi:10.1371/journal.ppat.1002481.g002
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from 10 ng/ml with a circa 50% decrease (Figure 4D). Metabolic
activity was thus low in LT-treated NK cells, whereas viability was
maintained.
NK cells possess a dual function, cytokine secretion and natural
cytotoxicity towards specific targets [1]. We determined whether
LT could also alter the cytotoxic activity of NK cells. LT
significantly reduced the ability of NK cells to kill the mouse YAC-
1 lymphoma target cell in vitro (Figure 5A). Thus, our results show
that NK cells are highly sensitive to LT subverting both functions,
leading to a strong inhibition of cytokine secretion and natural
cytotoxicity.
Similarly, ET disrupted the ability of splenocytes stimulated
with B. anthracis spores to produce both IL-12 and IFN-c in a dose-
dependent manner (Figure 3A and 3B). A dose of 10 pg/ml
significantly inhibited both IL-12 and IFN-c secretion, whereas the
Figure 3. Differential inhibition by ET and LT of the spore-induced IL-12 and IFN-c production by splenocytes. IL-12p40/p70 (A) and
IFN-c (B) production by splenocytes pre-incubated for 1 h with PA and increasing concentrations of LF or EF; spore stimulation was then performed
as in Figure 1A in the presence of toxins. (C) Similar incubation conditions as in (A,B) with either addition of rIL-18 or rIL-12p70, or IL-12
neutralization. The data represent mean cytokine concentrations of triplicates in culture supernatants (6 SD) representative of three independent
experiments. T test; *, P,0.05 compared with the group incubated with FIS without toxins.
doi:10.1371/journal.ppat.1002481.g003
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of IL-12 during spore stimulation did not restore the IFN-c
secretion (Figure 3C). In contrast, the ET-mediated inhibition was
reversed by addition of IL-18 (Figure 3C). This was related to the
persistence of a basal IL-12 secretion, as addition of neutralizing
antibodies for IL-12 abolished restoration of IFN-c production by
recombinant IL-18 (Figure 3C). These results strongly suggest that
ET blocked IFN-c production by acting mainly on macrophages,
as NK cells were still functional and able to secrete IFN-c.
To explore in detail the direct effects of ET on IFN-c secretion
inhibition in NK cells, IL12/18-stimulated purified NK cells were
exposed to graded doses of ET in the absence of accessory cells.
ET did not inhibit IFN-c production at doses up to 100 ng/ml,
and only slightly at the high dose of 1 mg/ml (Figure 4B), despite
expression of adenylate cyclase activity, detected by a marked
increase in intracellular cAMP (2.8-fold higher than in untreated
IL-12/IL-18-stimulated purified NK cells) (Figure 4E). In contrast,
ET significantly reduced the ability of NK cells to kill the YAC-1
Figure 4. Impairment of IFN-c production by LT in purified NK cells, contrasting with absence of effect by ET. (A,B) IFN-c production
by purified CD49b
+ cells pre-treated for 1 h with PA and increasing concentrations of LF or EF and then stimulated for the whole incubation time with
rIL-12 and rIL-18 in the presence of toxins. Data are mean 6 SD of triplicates and are representative of one experiment of three performed; SD values
are hidden by symbol size. T test; *, P,0.05 compared with the group incubated with PA only. (C) Inhibition of p38, JNK and ERK phosphorylation by
LT in purified CD49b+ cells activated by rIL-12 and rIL-18 for 10 min; total ERK1/2 was used as loading control. Data represent one of at least two
independent experiments. (D) NK cell viability (left panel; Live/Dead Cell Staining) and metabolic activity (right panel; MTS assay) after 18 h-
incubation with LT. *, P,0.05 compared to the untreated group. (E) Intracellular cAMP production by purified CD49b
+ cells treated with ET for 1 h.
Data are mean 6 SD of triplicates per condition and are representative of one experiment out of three. T test; *, P,0.05 compared with the untreated
group.
doi:10.1371/journal.ppat.1002481.g004
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when compared with the effects of a similar dose of LT (Figure 5A).
The above results show that: (i) ET and LT similarly disrupt
IFN-c production by spore-stimulated splenocytes, but the
mechanism of inhibition is different for each toxin; LT acts both
on macrophages and NK cells, whereas ET acts on macrophages,
and (ii) both ET and LT directly alter the innate ability of NK cells
to exert their natural cytotoxicity function.
During anthrax infection, B. anthracis toxins are present in the
infected tissues and circulate in the host vascular system. To
evaluate the functional consequences on the natural cytotoxic
activity of NK cells in vivo, we exploited an in vivo model of NK cell
cytototoxic activity relying on the capacity of NK cells to recognise
and eliminate MHC class I-deficient cells. Equal ratios of MHC
class I-deficient splenocytes (from C57BL/6 b2m
2/2, high CFSE
labeling) and wild-type C57BL/6 MHC class I-expressing
splenocytes (low CFSE labeling) (Figure 5B; ‘‘injected mix’’) were
injected intravenously into syngeneic wild-type C57BL/6 mice.
The elimination of the MHC class I-deficient b2m
2/2 cells was
quantified in the spleen relative to the MHC class I-expressing
cells [34]. In this in vivo model, MHC class I-deficient b2m
2/2
cells are rapidly eliminated 16–24 h following adoptive transfer,
through the natural cytotoxicity function of NK cells (Figure 5B
and 5C; non-treated; cytotoxicity of 94%). As controls, in vivo
activation of NK cells by injection of the classical NK cell cytotoxic
activator poly:(IC) [35] led to elimination of the MHC class I-
deficient cells (CFSE high) (Figure 5B). In contrast, in vivo depletion
of NK cells led to persistence of MHC class I-deficient cells
(Figure 5B).
Pretreatment of mice with ET (EF+PA) by intravenous
inoculation drastically inhibited clearance of the MHC class I-
deficient cells (CFSE high) (Figure 5B and 5C; remaining
cytotoxicity of 27%). This effect was related to the adenylate
cyclase activity of EF, as the Bordetella pertussis toxin CyaA, which
has a similar enzymatic activity, also inhibited the elimination of
the MHC class I-deficient cells (Figure 5B). EF, LF or PA alone,
and a mutated enzymatically inactive CyaA did not modify the
capacity of NK cells to specifically eliminate the MHC class I-
deficient cells (Figure 5B and S1D). LT (LF+PA) also decreased
MHC class I-deficient cell clearance, albeit to a lesser extent
(Figure 5B; remaining cytotoxicity of 51%). These results
demonstrate the high efficiency of B. anthracis toxins, especially
ET, in impairing the natural cytotoxicity of NK cells in vivo.
CD49b
+ and F4/80
+ cells are rapidly recruited to the
draining lymph nodes upon infection with B. anthracis
NK cells patrol the host tissues to detect and react to any danger
signal. No data are available on their involvement during B.
anthracis infection. We therefore visualised in vivo NK cell
recruitment into the initial infectious foci and the draining lymph
node. Biphotonic imaging was performed on the infected ear of
mice after inoculation with spores of an encapsulated toxin-
deficient B. anthracis strain (due to confinement restrictions, these
experiments could not be performed with encapsulated toxin-
Figure 5. ET efficiently inhibits NK cell cytotoxic activity in vitro and in vivo. (A) Pre-incubation of purified CD49b
+ cells with ET and LT
inhibits lysis of YAC-1 target cells. Data represent mean 6 SD (n=3) of one of at least three independent experiments. T test; *, P,0.05, ** P,0.01 as
compared with the no-toxin group. (B) In vivo effect of ET and LT on the natural cytotoxic activity of NK cells: C57BL/6 wild-type and syngeneic MHC
class I-deficient b2m2/2 splenocytes were differentially labeled with CFSE and adoptively transferred intravenously in equal number (‘‘injected mix’’)
into C57BL/6 syngeneic wild-type recipients; elimination of the MHC class I-deficient cells (CFSE high) was quantified 16–20 h later in the spleen and
confirmed to be mediated by the NK cell population of the recipients, either after in vivo NK cell activation by poly:(IC) injection, or after in vivo NK cell
depletion through injection of anti-NK1.1 antibodies (experiment 1). The effect on elimination of the MHC class I-deficient cells of ET, LT (experiments
1 to 3) or the toxin CyaA of Bordetella pertussis (or its inactive mutant CyaE5) (experiment 3) was then quantified: all toxins were injected
intravenously 8 h prior CFSE-labeled mixed cell inoculation. Controls were injected with PA, EF, or LF only; MHC class I-deficient cells were eliminated
as in the non-treated recipients (Figure S1D). Data represent histogram plots from three independent experiments showing relative percentages of
the high (MHC class I-deficient) and low (normal) CFSE cell populations. (C) Mean percent specific lysis of MHC class I-deficient cells of 3 independent
assays performed. The percent specific lysis was calculated as described in Materials and Methods. T test; *, P,0.05 compared to the untreated group.
doi:10.1371/journal.ppat.1002481.g005
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PLoS Pathogens | www.plospathogens.org 8 January 2012 | Volume 8 | Issue 1 | e1002481Figure 6. Recruitment and role of NK cells during B. anthracis infection and impact of in vivo toxin production. (A) Circulating NK cells
5 h post-inoculation, viewed by biphoton imaging; dermal collagen in blue (SHG), vascular flow in red (rhodamine B) and NK cells in green (CFSE);
scale bar=20 mm; time-scale in milliseconds indicated on each image. (B) Adherent, then rolling NK cell 5 h post-inoculation; scale bar=20 mm; time-
scale in seconds indicated on each image. (C) Extravasated NK cells at 18 h post-inoculation; scale bar=10 mm (top), 40 mm (bottom). (D)
Subcapsular NK cell in the cervical lymph node draining the infected ear 18 h post-inoculation; NK cells in green (CFSE) and capsular collagen in blue
(SHG); scale bar=20 mm. Data representative of 3 mice. (E) Absolute numbers of CD49b
+ (left panel) and F4/80
+ cells (right panel) in the cervical
lymph node draining the site of cutaneous infection with spores of the 9602P(PA2EF+LF+), 9602L(PA+EF+LF2), 9602C(PA+EF2LF+) strains 24 h
post-inoculation (2.9160.03 log10 CFU per mouse). Controls were injected with PBS. Each symbol represents the value for an individual mouse;
horizontal lines indicate the mean value for each group. Data are pooled from two independent experiments. T test; **P,0,01 as compared with the
9602P-injected group. (F) In vivo effect of NK cell depletion on systemic bacterial dissemination in the spleen. Bacterial load was determined 18 h
after infection into the ear with spores of the 9602P strain (3.0560.29 log10 CFU per mouse). Data are pooled from two independent experiments.
T test; *, P,0.05; **, P,0,01 as compared with the non-treated group.
doi:10.1371/journal.ppat.1002481.g006
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through intravenous adoptive transfer of CFSE-labeled purified
NK cells in mice whose blood vascular system was labeled through
injection of dextran-rhodamine (Figure 6A–D). During the first
5 h of infection, NK cells were observed circulating in the ear
capillaries (#20 mm diameter) in both infected and control ears
(Figure 6A). Occasionally, long-term (more than 6 sec) interaction
of NK cells with the capillary endothelium could be observed in
the infected ear (Figure 6B). At 24 h of infection, NK cells were
observed in the infected ear tissue, outside the vascular bed in the
collagen-rich tissue (as visualised in blue by the second harmonic),
either close to the vascular lining (Figure 6C, top), or at a distance
(Figure 6C, bottom). At this time of infection, NK cells began to be
observed in the capsular sinus of the draining lymph nodes
(Figure 6D). Thus, infection with spores of B. anthracis triggers
recruitment of NK cells into the local site of infection and further
migration into the subcapsular sinus of the draining lymph node,
where these cells could exert their functions.
We then determine the early in vivo impact of toxin secretion by
nascent bacilli on the local NK cell response. To this end, we
characterised the recruitment of NK cells and macrophages into
the draining lymph node at 24 h of infection with the encapsulated
toxin-deficient B. anthracis strain, and its encapsulated derivatives
expressing either ET or LT (Figure 6E). The total number of
lymphoid cells and the percentage of F4/80
+ cells and CD49b
+
cells was increased in the draining lymph node of the encapsulated
toxin-less infected mice, compared with the lymph node from
PBS-injected mice (data not shown). Compared with an uninfected
lymph node, the absolute number of CD49b
+ cells (Figure 6E, left
panel) and F4/80
+ cells (Figure 6E, right panel) in the infected
draining lymph nodes significantly increased by nine-fold and six-
fold respectively; p,0.01). Production of either ET or LT during
infection with the encapsulated strains 9602L(EF+PA+)o r
9602C(LF+PA+) led to a significant decrease in the number of
CD49b
+ and F4/80
+ cells in the infected lymph node, as
compared with lymph nodes from mice infected with the
encapsulated toxin-deficient strain (Figure 6E; p,0.01). These
results clearly indicate that infection with B. anthracis spores is
recognized by the innate immune system, leading to early
recruitment of NK cells into the cutaneous tissue, and recruitment
of NK cells and macrophages into the draining lymph node.
Through the action of its toxins, B. anthracis blocked recruitment of
both NK cells and macrophages.
To define the role of NK cells in B. anthracis infection, the effect
of in vivo NK cell depletion was characterised. Accelerated systemic
dissemination of the bacteria from the site of infection was
observed, with early bacterial seeding of the spleen in NK-depleted
mice versus control infected mice (Figure 6F). This result
demonstrates the in vivo role of NK cells in controlling early B.
anthracis dissemination.
Discussion
In the present study, we have provided insight into the
mechanisms of cytokine and cellular signaling that enable B.
anthracis spores to efficiently drive IFN-c production by NK cells.
We also showed how B. anthracis toxins may allow the bacteria to
avoid immune clearance by altering cytokine production and
natural cytotoxicity.
The communication between NK cells and spore-activated
macrophages was both cytokine- and contact-dependent and
involved engagement of the NKG2D receptor. Our data indicate
that macrophage-derived cytokines alone, or direct stimulation of
NK cells by B. anthracis spores alone, are not sufficient to drive
activation of NK cells, as assessed by CD69 and IFN-c expression.
Although IL-12 was secreted by spore-stimulated macrophages,
NK cell activation did not occur when cellular interactions
between NK cells and macrophages were prevented. Thus, cell-
cell contact was a critical factor in macrophage/NK-cell
interactions. Contact dependency involved at least engagement
of the activating NKG2D receptor with one of its main ligands on
the macrophage, RAE-1 [36], whose expression was upregulated
upon spore stimulation. Stimulation with various TLR agonists
leads to surface expression of RAE-1 on macrophages [37]. RAE-
1-NKG2D interactions contribute to IFN-c production and
provide a molecular mechanism by which NK cells and infected
macrophages communicate directly during an innate immune
response to infection [38]. The requirement for direct contact
between NK cells and macrophages for full NK cell activation
might in part also be a manifestation of the dependency of NK
cells on cytokine-mediated signals delivered when contact is
established. For example, delivery to NK cells of IL-15 and IL-18
produced by macrophages and dendritic cells occurs in a synaptic
manner, so that as soon as the cytokines are secreted, they are
captured by the secreting or target cell [39,40]. Secreted IL-15, for
example, is immediately bound by the IL-15 receptor-a expressed
on the surface of the accessory cells and is presented to NK cells in
a cell-contact dependent manner [41]. Similarly, IL-18 is delivered
to NK cells through cell contact with dendritic cells [39]. The IL-
12 receptor may also localise at the contact zone between NK cells
and macrophages [4], indicating that direct contact might be
pivotal for efficient delivery of IL-12 to NK cells [42]. Our data
are thus consistent with the strict contact-dependency of NK-cell
activation, as these three cytokines are induced under spore
stimulation and are strictly required for NK cell activation.
We demonstrated a predominant implication of IL-12 and IL-
18 in NK-cell activation by B. anthracis spores, and to a lesser
degree of IL-15; these cytokines were secreted by the spore-
stimulated macrophages. However, individually, IL-12, IL-15, and
IL-18 failed to induce effector responses in purified NK cells. IFN-
c production was almost abolished when both signals from IL-15
and IL-18 were simultaneously absent. These observations
strongly suggest a synergistic mechanism of action of IL-12 with
IL-15 and/or IL-18. Endogenous IL-15 produced by LPS-
activated monocytes works in concert with IL-12 for optimal
IFN-c production by NK cells [43]. Several studies have shown
that IL-18 responsiveness is dependent upon IL-12 and vice versa
for T cells [44,45]. IL-12 and IL-18 are considered important
mediators of IFN-c production by NK cells and T lymphocytes
[46]. The molecular mechanism underlying the synergy between
IL-18 and IL-12 may be explained in part by reciprocal
modulation of cytokine receptor expression. Specifically, IL-18
upregulates IL-12R expression [47], whereas IL-12 upregulates
expression of the IL-18R [48].
In our model, liberation of IL-18 was probably a primary event
in response to B. anthracis spores. Short-term pretreatment with IL-
18 prior to stimulation with spores fully restored IFN-c
production, even when IL-18 paracrine activity was later
neutralized. In contrast, IL-12 was required for a longer time
period to obtain full restoration of IFN-c secretion. This may
reflect differences in storage and delivery for these two cytokines.
IL-18 is stored as a biologically inactive precursor in secretory
organelles of the endolysosomal compartment and, upon stimu-
lation, can be rapidly released into the extracellular milieu after
cleavage by caspase-1 [49,50], whereas IL-12 needs to be
synthesised and secreted along the classical secretory pathway
[51].
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produced by spore-activated macrophages, and demonstrate that
it acts both on NK cells and macrophages. Absence of the IL-12
receptor on NK cells reveals the secondary key role of IL-18. For
macrophages, the absence of the IL-12 receptor greatly decreased
their capacity to provide the necessary accessory signals to NK
cells. Indeed, a general and critical role of IL-12 in potentiating the
accessory function of myeloid antigen presenting cells has been
suggested by Grohmann et al [52]. IL-12 is thus not only a
connective element between accessory cells and lymphocytes, but
also a key molecule for programming macrophage and dendritic-
cell functions [53,54].
We demonstrated that the inflammatory response induced by B.
anthracis spores requires MyD88-mediated signaling both on
macrophages and NK cells. MyD88 is an adaptor protein which
is essential for signaling downstream of many TLRs, and also of
IL-18 and IL-1 receptors [55]. MyD88-implication in the NK cell
response was thus expected, as IL-18 is crucial for NK cell
activation by B. anthracis spores. On the other hand, MyD88-
dependence of spore recognition by macrophages, leading to
deficient IL-12 secretion and, by way of consequence, absence of
NK cell activation, shows that it is pathogen-pattern based.
However, the interactions between the components of the highly
complex spore particle and TLRs or related receptors still need to
be characterised in detail. Spore recognition most probably
involve several receptors; knocking-out one or more TLRs has
indeed been reported not to modify the biological response
observed, either in vitro [10] or in vivo (Tod Merkel, personnal
communication).
IL-18 is a proinflammatory cytokine that belongs to the IL-1
cytokine family. IL-18 and IL-1 are related in terms of structure,
processing, receptor and signaling pathways [56]. Secretion of the
active form of both cytokines is dependent on caspase-1 activation
that is required for the processing of the IL-1 and IL-18 precursors.
Release of mature IL-18 depends on concomitant activation of
caspase-1 and TLR engagement by pathogen-derived agonists [56].
Thissuggests that spore recognition is able to deliver both activation
signals. IL-18 amplifies the innate immune response by inducing the
expression of cytokines and chemokines such as IL-1b, TNFa and
IL-8. The macrophage cytokine response could thus be triggered
both directly and indirectly by the spores.
B. anthracis toxins were highly efficient in subverting the innate
immune response, triggered by B. anthracis spores through
activation of macrophages and induction of IFN-c secretion by
NK cells. Even at very low doses, the toxins disrupted IFN-c
production by spore-stimulated splenocytes. They altered both
contact-dependent and cytokine-dependent signaling. Both toxins
reduced expression of RAE-1 on the surface of spore-stimulated
macrophages, thus decreasing signaling through the activating
receptor, NKG2D. Indeed, defects in the expression of RAE-1
molecules have been hypothesized to contribute to reduced NK
cell function [57]. The mechanisms of inhibitory action for each
toxin on cytokine secretion were different. LT targeted both
macrophages and NK cells, whereas ET blocked the macrophage
activating functions but did not affect the IFN-c secretion capacity
of NK cells. Impairment of IFN-c production by ET depended
mainly on inhibition of IL-18 production by macrophages, a
primary event in NK cell stimulation. Basal IL-12 secretion by
macrophages was not affected and was sufficient to drive normal
amounts of IFN-c secretion by NK cells when the external IL-18
concentration was restored.
A number of studies have addressed the effects of LT and ET on
cytokine secretion and their consequences on immunity
[18,58,59]. While LT inactivation of MKK signaling pathways
leads to almost invariable inhibition of the innate immune
response, ET-induced cAMP increase results in a complex
immunomodulatory effect. LT inhibits, whereas ET differentially
regulates the release of pro-inflammatory cytokines in macro-
phages and DCs [22,60,61].
Our results on ET-induced IL-12 inhibition are consistent with
previous reports of an inhibitory effect of ET on macrophages and
DCs [22]. Of note is our observation that ET has a dominant
effect on IL-18 secretion. Secretion of IL–18 by activated
macrophages depends on the protease caspase-1 that converts
the IL-18 precursor to the mature and biologically active cytokine
[62,63]. Caspase-1 activation is induced by B. anthracis spores and
has been suggested to play a critical role in host defences against B.
anthracis infection in vivo [64]. LT has also been reported to induce
caspase-1 activation which results in IL-1b and IL-18 intracellular
processing [64]. However, the release of these cytokines occurs as
a passive event, resulting from cell death and lysis [65].
NKT cells are a specialized subset of T lymphocytes sharing
both T cell and NK cell markers with the capacity to recognise
microbial glycolipid antigens [66]. However, their modes of
recognition are distinct from NK cells and their functions are quite
different [67]. The effect of LT on NKT cells has recently been
explored after stimulation with their classical cognate ligand, a-
galactosylceramide [23]. LT was reported to induce an anergy-like
unresponsiveness in NKT cells following stimulation via their T
cell receptor [23].
Oneofthebest characterisedfunctions ofNKcellsistheirnatural
cytotoxic activity against virus-infected cells or cells undergoing
tumor transformation [35]. The present study showed that both ET
and LT directly altered the innate ability of NK cells to exert their
naturalcytotoxicfunction,bothinvitroand,mostimportantly,invivo.
Furthermore, ET exerted a much stronger inhibitory effect than
LT.EF-the enzymaticmoietyofET-isanadenylatecyclaseleading
to elevated concentrations of intracellular cAMP [16]. We
demonstrated that similar in vivo inhibition of the NK cell cytotoxic
activity was also induced by the CyaA toxin of Bordetella pertussis.
Thus, as a bacterial adenylate cyclase, CyaA toxin produces the
same end-effect i.e. increase of intracellular cAMP [68]. These data
thus strongly suggest that inhibition of NK-cell cytotoxic activity by
ET is mediated via the activation of cAMP downstream pathways.
We thus provide the first demonstration that the ET subverting
action leads to dissociation in NK-cell function, which strongly
blocks natural cytotoxicity without affecting IFN-c secreting
capacity. Its high efficiency stresses the impact this toxin may exert
on anthrax pathogenesis. NK cell-associated receptors have been
implicated in certain autoimmune diseases [69,70] and NK cells
have been suggested to play a role in modifying T cell-mediated
autoimmunity. As the cytotoxic activity of cytotoxic CD8 T cells
shares at least in part, common mechanisms with NK cells [71], we
believe these AMPc-elevating compounds could be of use to inhibit
the deregulated or increased cytotoxic activities that underlie NK or
CTL-dependent autoimmune pathology [72].
Our in vivo data show that NK cells are rapidly recruited into the
cutaneous tissue infected by B. anthracis. Both NK cells and
macrophages were detected early in the draining lymph node in
the absence of toxin secretion. In contrast, production of either ET
or LT during infection drastically inhibited this local immune
response. The reduced inflammatory response could be related to
the immunosuppressive activities of LT and ET [59]. By increasing
the intracellular concentration of cAMP and cleaving MKKs, B.
anthracis toxins have the potential to interfere with chemotactic
signaling for neutrophils, T-cells and macrophages [14,20,73].
Considering that -in the context of anthrax infection- macrophages
appear to afford protection to the host [14,74], it is not surprising
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macrophage functions such as their migration to lymph nodes.
We furthermore demonstrated that NK cells controlled the
infectious process, as in vivo NK cell depletion resulted in an
increased bacterial dissemination to the spleen. Conceptually, NK
cell depletion could mimick the consequences of NK cell
inactivation by the toxins. Clearly, further experiments are needed
to address how NK cells control in vivo spreading of bacteria during
anthrax infection. In a previous study, we showed the central
impact of ET on bacterial control of dissemination in the draining
lymph node, both after cutaneous and inhalational infections [75].
The draining lymph node thus appears to be the key organ for
delaying bacterial systemic dissemination. We postulate that this
control most probably occurs through direct interactions between
NK cells and accessory cells, resulting in IFN-c production and
macrophage activation of their bactericidal activity. NK cells
respond to pathogens through both cytokine secretion and natural
cytotoxicity. The relative impact of each NK function on the
development of an infectious process depends on the type of
infection [5]. Natural cytotoxicity has mainly been characterised
against tumoral or virally-infected targets cells [76]. Direct natural
cytotoxicity to infected cells in bacterial infections has rarely been
reported, primarily with intracellular pathogens (Mycobacterium sp.,
Listeria monocytogenes; [5]). As B. anthracis is an extracellular
pathogen, we hypothesise that NK cell cytotoxic activity may
potentially occur either at the initial infection step, when a
proportion of the infecting spores are phagocytosed by accessory
resident cells such as macrophages or dendritic cells - which could
provide the necessary contact- and cytokine-dependent signaling
to the NK cells, or, at a later stage of infection, through
recognition by NK cells of cellular stress induced by the toxins.
The potential role of NK cell cytotoxicity during B. anthracis
infection remains to be explored in depth.
The present study is the first to investigate the direct modulation
of NK cell functions, IFN-c producing capacity and natural
cytotoxicity, by B. anthracis, and their subversion by ET and LT.
Our findings exemplify the delicate balance between stimulation of
the initial host control mechanisms by B. anthracis spores and the
bacterial evasion strategies to overcome these innate host defences.
NK cells are important immune effectors for preventing microbial
invasion and dissemination [77], performing their surveillance
function and establishing intercellular communications at an early
stage of infection. The model we propose hypothesises that
interactions of macrophages and dendritic cells with the infecting
spores and spore components would lead to NK cell activation and
IFN-c production, through a combination of signals derived from
intercellular contacts with macrophages and from cytokines
secreted by these cells. The accumulation of NK cells and
macrophages in the appropriate cytokine environment of the
infected lymph nodes will thereby amplify the inflammatory
response. Such a positive feedback loop is likely to be important in
the control and pathogenesis of anthrax. Furthermore, by
secreting toxins, nascent B. anthracis bacilli will alter spore-induced
contact-dependent signaling and cytokine production. This will
prevent efficient immune-cell contacts and initiation of inflamma-
tion and inflammatory-cell recruitment into the infected draining
lymph node, resulting in successful bacterial colonization and
spreading of infection.
Materials and Methods
Ethics statement
All the animal experiments described in the present study were
conducted at the Institut Pasteur according to the European
Union guidelines for the handling of laboratory animals (http://
ec.europa.eu/environment/chemicals/lab_animals/home_en.htm)
and were approved by the animal care and use committee at the
Institut Pasteur. All efforts were made to minimize suffering.
Bacterial strains and mice
RPLC2 is a Sterne derivative that produces inactive lethal and
edema factors mutated in their enzymatic site [78]. The 9602P
(delta-pagA), 9602C (delta-cya) and 9602L (delta-lef) strains [75] are
derivatives of the highly virulent natural human isolate 9602 [79].
RPLC2 spores were produced, purified on Radioselectan
(Renografin 76%, Schering) and formaldehyde-inactivated as
previously described [80,81]. Formaldehyde-inactivated spores
(FIS) were quantified using a Malassez counting chamber and
inactivation was confirmed by plating on BHI agar. Heat
inactivation was carried out as previously described [10]. B.
subtilis strain SMY was a kind gift from Abraham L. Sonenshein
(Department of Molecular Biology and Microbiology, Tufts
University School of Medicine, Boston, USA) and spore
inactivation was performed as for B. anthracis. The germination-
deficient mutant on the 7702 background was constructed by
inactivation of the cwlD, sleB and cwlJ1 genes through double
crossing-over insertion of antibiotic cassettes (spectinomycin,
erythromycin and kanamycin respectively) using techniques as
previously described [82] (Manuel Lopez-Vernara, Fabien Bros-
sier and Miche `le Mock, unpublished results). Germination was
decreased by at least 6 log10 on BHI agar. The inoculum used in
the in vitro cell infection assays (2610
6 spores per well, as assessed
by counting in a Malassez chamber) did not give rise to any CFU
upon numeration.
Six- to 10-week-old C57BL/6 and FVB female mice were
purchased from Charles River (L’Arbresle, France). CD1d-
deficient C57BL/6 mice lacking both CD1d1 and CD1d2 [83]
were a kind gift from Dr Claire-Lise Forestier (G5 Parasite
Virulence, Institut Pasteur, Paris, France). b2m-deficient C57BL/
6 mice, B6.129P2-B2m
tm1Unc/J (Jackson Laboratory), were a kind
gift from Dr Matthew Albert (Dendritic Cell Immunobiology,
Institut Pasteur, Paris, France). The IL-12Rb2-deficient and IL-
12p35/p40-deficient C57BL/6 mice (both from Jackson Labora-
tory) were kindly provided by Dr Selina Keppler (University
Hospital Freiburg, Institute of Medical Microbiology and
Hygiene, Freiburg). The MyD88-deficient mice obtained from
the laboratory of Shizuo Akira were backcrossed eight times to the
C57BL/6 background [55] and bred in the central animal facility
of the Pasteur Institute. The animals were housed in the animal
facilities of the Institut Pasteur licensed by the French Ministry of
Agriculture and complying with the European regulations. The
protocols were approved by the safety committee at the Institut
Pasteur according to the standard procedures recommended by
the animal care and use committee at the Institut Pasteur.
Cell activation assay and immunodetection of cytokines
Single spleen cell suspensions were prepared by mechanical
disruption on a cell strainer (70 mm pore diameter, BD
Biosciences, Bedford, USA) in Dulbecco’s D-PBS (Invitrogen).
Red blood cells were lysed using Hemolytic Gey’s Solution as
previously described [10]. NK cells were purified using the
EasySep Mouse panNK (CD49b) Positive Selection Kit (StemCell
Technologies, Vancouver, British Columbia, Canada) according
to the manufacturer’s protocol. Flow cytometry analysis showed
the purity of NK cells to be more than 90%. Further purification
(.98%) was performed using a MoFlo cell sorter (Beckman-
Coulter). Bone marrow-derived macrophages (BMDMs) were
obtained from the femur of mice after differentiation for 8 to 10
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CSF (PeproTech, Levallois-Perret, France) on bacterial petri
dishes. BMDMs were mature as assessed by expression of the F4/
80 surface marker (consistently over 90% F4/80 positive). Cell
enumeration and viability (.90%) was routinely assessed by
acridine orange/propidium iodide staining.
All cell cultures were carried out in RPMI 1640 medium+Glu-
taMAXTM I (Invitrogen, Cergy-Pontoise, France) supplemented
with 10% fetal calf serum (FCS; BioWest, Nuaille ´, France),
100 mg/ml penicillin/streptomycin (Invitrogen), and 50 mM2 -
mercaptoethanol (Invitrogen). All reactivation conditions were
performed in triplicate.
Cell activation was performed by incubating either 2610
5
splenocytes, or 2610
5 purified NK cells with 2610
5 BMDM, with
2610
6 spores (or polystyrene latex beads 21.1 mm mean particle
size-, Sigma, Aldrich) in a final volume of 200 ml in 96-well tissue
culture plates (TPP, Trasadingen, Switzerland) for 1 to 3 days.
Direct stimulation of purified NK cells was performed by adding
to the culture medium endotoxin-free mouse rIL-12 (10 ng/ml,
BD Pharmingen) and endotoxin-free mouse rIL-18 (20 ng/ml,
MBL International) for 18 h. In some experiments, NK cell
activation was performed in 96-well Transwell plates (0.4 mm pore
diameter; Corning Costar, NY); BMDMs (3.1610
5 cells in 235 ml)
mixed with FIS (3.1610
6) were seeded into the outer chamber;
CD49b
+ NK cells (3.1610
5 cells in 75 ml) were added either
directly to the outer chamber, or placed into the inner chamber
along with or without 3.1610
6 FIS. Cytokine and receptor
function were blocked by addition of the following azide-free, low-
endotoxin anti-mouse cytokine or receptor-specific mAbs: rat anti-
mouse IL-12p40/p70 (5 mg/ml, clone C17.8, BD Pharmingen)
and its isotype control (clone R35-95, BD Pharmingen), rat anti-
mouse IL-18 (10 mg/ml, clone 93-10C, MBL International
Corporation) and its isotype control (clone eBRG1, eBioscience),
goat anti-mouse IL-15Ra polyclonal (10 mg/ml, R&D Systems),
armenian hamster anti-mouse NKG2D (10 mg/ml, clone C7,
eBioscience) and its isotype control (clone eBio299Arm,
eBioscience), rat anti-mouse RAE-1 (5 mg/ml, clone 199205,
R&D Systems) and its isotype control (clone R35-95, BD
Pharmingen), rat anti-mouse IFN-a (5 mg/ml, clone RMMA-1,
PBL Biomedical Laboratories), rat anti-mouse IFN-b (5 mg/ml,
clone RMMB-1, PBL Biomedical Laboratories), goat anti-mouse
NKp46 polyclonal (10 mg/ml, R&D Systems), rat anti-mouse IL-
10 (10 mg/ml, clone JES5-2A5, BD Pharmingen), armenian
hamster anti-mouse TNF-a (10 mg/ml, clone TN3-19.12, Sigma).
For analysis of the effects of the toxins, splenocytes were pre-
treated before stimulation, for 1 h with rPA (250 ng/ml) and/or
either rLF (0.01–100 ng/ml), -both a kind gift from Dr Bassam
Hallis, HPA, Porton Down, UK-, or rEF (0.01–100 ng/ml) -a kind
gift from Pr Wei-Jen Tang, University of Chicago, Chicago, USA.
Purified CD49b
+ NK cells were pre-treated before stimulation for
1 h with PA (250 ng/ml) and/or either LF (0.5–100 ng/ml) or EF
(10–100 ng/ml), or PA (2500 ng/ml) and EF (500–1000 ng/ml).
NK cell viability after toxin treatment was analyzed by using Live/
Dead Cell Staining Kit (Invitrogen) and their metabolic activity
was assessed by the CellTiter 96 AQueous One Solution Cell
Proliferation Assay (MTS) (Promega).
In all cases, cell-free supernatants were removed at specific time
points and frozen at 220uC before subsequent ELISA analysis for
IFN-c or IL-12. When mentioned, conditioned supernatants from
FIS-activated BMDM were collected after a 24-h stimulation,
transferred on purified CD49b
+ NK cells and incubated for a
further 48 h. ELISA was performed as previously described [10]
using the following antibody pairs and protein standards (all from
BD Pharmingen, Le-Pont-de-Claix, France): for IL-12p40/p70,
capture with mAb clone C15.6, detection with mAb clone C17.8,
standard recombinant mouse IL-12 (p70); for IFN-c, capture with
mAb clone R4-6A2, detection with mAb clone XMG1.2, standard
recombinant mouse IFN-c.
Flow cytometry
Cell staining was performed with the following mAbs: anti-
mouse CD69-fluorescein isothiocyanate (FITC) (clone H1.2F3)
(BioLegend, San Diego, USA) and its FITC-conjugated isotype
control (Caltag laboratories), CD49b- phycoerythrin (PE) (clone
DX5) (BD Bioscience, San Diego, CA), IFN-c-FITC (clone
XMG1.2) (BD Bioscience, San Diego, CA) and its FITC-
conjugated isotype control (BioLegend), F4/80-allophycocyanine
(APC) (clone BM8) (BioLegend), pan-RAE-1-PE (clone 186107)
(R&D Systems) and its PE-conjugated isotype control (Caltag
Laboratories). To obtain a single-cell suspension, collected cells
were pre-treated in 5 mM EDTA/PBS to dissociate cell
aggregates. Cells were subsequently washed and blocked for
10 min with anti-CD16/CD32 mAb (BioLegend) in FACS buffer
(Dulbecco’s PBS, 2% heat-inactivated FBS, 10 mM sodium azide)
and then labeled with the appropriate antibodies. Dead cells were
excluded during acquisition through staining with LIVE/DEAD
Fixable Dead Cell Stain Kit according to the manufactor’s
procedure (Invitrogen). For intracellular cytokine staining [84],
cells were incubated with brefeldin A (5 mg/ml, Sigma, Aldrich)
for the last 4 h of activation with the spores. After labeling with
DX5-PE mAb, fixation in 2% paraformaldehyde and permeabi-
lisation in 0.5% saponine, the cells were stained with anti-IFN-c-
FITC mAb for 30 min. Cell acquisition was performed using a
FACSCalibur flow cytometer (BD Bioscience). NK cells were
gated by their light scattering properties -forward (FSC) and side
(SSC) scatter- that distinguished them from the macrophages
(Figure S1A). Isotype controls Abs were used for each staining
combination. A minimum of 10,000 events was acquired for
analysis. Data were acquired and analyzed using CELLQUEST
software (BD Bioscience). Figures were derived by free WinMDI
Software (Version 2.8, Bio-Soft Net; WinMDI software [http://
en.bio-soft.net/other/WinMDI.html]).
CFSE-based in vitro cytotoxicity assay
Natural cytotoxicity assay was performed as previously
described [85]. Briefly, the mouse lymphoma YAC-1 target cells
were labeled with 2.5 mM CFSE (Sigma, Aldrich) at 2610
6 cells/
ml for 8 min at room temperature. After dilution by 1:5 in
complete medium and 2 washing steps, the CFSE-labeled target
cells were resuspended in complete medium (4610
4 cells/ml,
100 ml/tube) and mixed with positively selected CD49b
+ cells at
an effector/target cell ratio (E/T ratio) of 50:1 (final volume:
200 ml) in 5 ml Falcon round-bottom tubes (BD Bioscience). When
necessary, CD49b
+ cells were treated for 4 h with PA (250 ng/ml)
and/or either LF (100 ng/ml) or EF (100 ng/ml), and then
washed prior to mixing. The cells were then incubated in the
presence of 10 ng murine rIL-2 (BioLegend) in a humidified
atmosphere of 5% CO2 at 37uC for 18 h. Cytotoxicity was then
assessed by flow cytometry analysis after propidium iodide
labeling. Negative controls were CFSE-labeled target cells without
NK cells.
For data analysis, the CFSE-stained target cells were gated (R1)
on SSC/FL1(CFSE) parameters and analyzed on FL1(CFSE)/
FL3(Propidium iodide). For each sample 4000 events of R1 were
collected. The percentage of specific target cell death was
calculated as follows: [(dead CFSE-positive targets in the sample
(%)2spontaneously dead CFSE-positive targets (%))/(1002spon-
taneously dead CFSE-positive targets)]6100.
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Spleen cells from C57BL/6 and b2m
2/2 C57BL/6 mice were
labeled with 2 mM (C57BL/6) or 5 mM( b2m
2/2 C57BL/6)
CFSE, and equal cell numbers (10
6; ‘‘injected mix’’) were co-
injected intravenously into C57BL/6 mice recipients, either
untreated or injected intravenously 8 h prior to cell inoculation
with (i) LF (7.5 mg) or EF (7.5 mg) and PA (20 mg) or (ii) CyaA or
the inactive mutant CyaE5 (15 mg) of Bordetella pertussis (a kind gift
from Dr Daniel Ladant, Biochimie des Interactions Macromole ´-
culaires, Institut Pasteur, Paris, France). Control mice received
either EF or PA alone. In vivo NK cell depletion was performed by
intravenous injection of 200 mg anti-NK1.1 mAb (clone PK136,
Serotec, Oxford, United Kingdom). In vivo NK cell activation was
performed by intravenous injection of 100 mg poly:(IC) (Invivo-
gen). Single spleen cell suspensions were prepared 16 h later and
the CFSE positive cell population was acquired by FACS as
described above. The ratio of CFSE high versus CFSE low cells was
determined and specific lysis was calculated as described [86]:
1006[12(ratio of injected mix/recovery ratio)], where ratio=%
CFSE low/% CFSE high.
MAPK phosphorylation and cAMP assays
Purified NK cells (10
6 cells) were incubated with PA (250 ng/
ml), and/or LF (100 ng/ml) for 2 h at 37uC. Recombinant IL-12
(50 ng/ml) and IL-18 (100 ng/ml) were then added for 10 min,
cells were washed twice with cold PBS and lysed on ice for 30 min
with a total protein extraction buffer (20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1 mM sodium EDTA, 1 mM EGTA, 1% Nonidet
P-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate,
1m Mb-glycerophosphate, 1 mM Na3VO4, 1 mg/ml leupeptin)
containing Complete protease and phosphatase inhibitor tablets as
specified by the manufacturer (Roche Diagnostics). Total protein
(50 mg as determined by the Bradford assay, Bio-Rad Laborato-
ries) was resolved on 10% SDS-PAGE gels and transferred to
nitrocellulose membranes. Membranes were blocked in TBS
containing 5% non-fat dried milk and 0.1% Tween 20. Protein
detection was performed with polyclonal Abs directed against
phospho-p38 MAPK, phospho-p42/44 (ERK 1/2) MAPK,
phospho-JNK or total p42/44 (ERK 1/2) MAPK (all from Cell
Signaling Technology). Total p42/44 (ERK 1/2) MAPK was used
as loading control as previously described [87]. Bands were
visualized with appropriate secondary HRP-conjugated Abs and
SuperSignal West Pico chemiluminescent substrate (Pierce). When
reprobed, membranes were first stripped by incubating in a
stripping buffer (Gene Bio-Application Ltd.).
To determine the cAMP response generated by edema toxin,
purified CD49b
+ NK cells (10
6 cells) were incubated with PA
(0.25 mg/ml) and EF (0.05–0.1 mg/ml), or PA (2.5 mg/ml) and EF
(0.5–1 mg/ml) at 37uC for 1 h and then stimulated with rIL-12
(10 ng/ml) and rIL-18 (20 ng/ml). After 2 h of incubation, the
culture medium was discarded and the cells were lysed with 0.1 M
HCl. After centrifugation, the supernatants were collected and
immediately stored at 280uC before analysis. Intracellular cAMP
concentration was determined using a commercial cAMP EIA kit
(Cayman Chemical, Ann Arbor, MI, USA) according to the
manufacturer’s instructions.
Isolation of lymph node cells and flow cytometry
FVB mice were infected into the ear dermis with spores of the
non-toxinogenic encapsulated 9602P (EF+LF+) strain, or the
9602L (EF+PA+) or 9602C (LF+PA+) strains. Cutaneous infec-
tions were performed under light anesthesia by injecting
2.9160.03 log10 spores per mouse in 10 ml of PBS into the dermis
of the left ear as previously described [88]. 24 h later the cervical
lymph nodes draining the infected site were excised, placed into
ice-cold saline solution and mechanically dissociated to obtain
single-cell suspensions. Control lymph nodes were obtained from
PBS-inoculated ears. Cell labeling was performed with APC-
conjugated anti-F4/80 (BioLegend), anti-CD4-FITC (BD Phar-
Mingen), anti-CD8-PE (BD PharMingen), and PE-conjugated
DX5 (eBioscience). Flow cytometry acquisition was performed as
described above.
Effect of NK cell depletion upon B. anthracis infection
NK-cell depletion was performed in C57BL/6 mice by
intraperitoneal injection of 200 mg of anti-NK1.1 antibody (clone
PK136, Serotec, Oxford, United Kingdom) at 2 days and 1 day
before infection. Depletion of NK cells (.95%) was verified in the
spleen by flow cytometry. Control mice received an injection of
200 mg isotype-matched antibody (Sigma). Cutaneous infection in
the ear was performed by injection of 3.0560.29 log10 spores of
the 9602P strain. Spleens were removed aseptically 18 h post-
inoculation and homogenized in 5 ml of PBS. The bacterial load
in the resulting suspensions was determined by plating 100 mlo f
10-fold dilutions onto BHI agar plates and is expressed as log10
CFU per spleen.
Two-photon excitation fluorescence in vivo imaging
C57BL/6 mice were subcutaneously infected with 2610
3 spores
of the non-toxigenic encapsulated B. anthracis strain in 10 ml of PBS
into the external face of the right ear, while the same volume of
PBS was injected in the left ear. Prior to imaging, 100 mgo f
rhodamine B 10 kD-dextran (Sigma) were administrated by
intravenous injection. Negatively selected NK cells (Negative
selection mouse NK cell enrichment kit, StemCell Technologies)
were labeled with 5 mM of CFSE and were injected intravenously
(10
6 per mice) 4 h after infection. Ketamine-xylazine anesthetized
mice were placed under the microscope with their ears maintained
between cover glasses. The cervical lymph nodes draining the
infected and the PBS-injected control ears were harvested from the
recipient mice 24 h after infection, fixed with tissue glue to the
plastic chamber containing PBS, and sequentially imaged. Two-
photon excitation fluorescence (TPEF) imaging was performed
using a LSM 710 Zeiss microscope. The excitation wavelength is
854 nm, allowing epicollection of second-harmonic generated
signal (SHG) at 427 nm quasi specific of collagen. Other
epicollected signals were intravenous rhodamine B and CFSE-
stained NK cells fluorescence. Image acquisition and analysis were
performed by using ZEN 2008 software (Zeiss).
Statistical analysis and software
Statistical analysis was performed using Graphpad Prism
software. Unless otherwise noted, results are expressed as mean
values 6 standard deviation. The student’s t-test was used to
determine significance (P,0.05).
Supporting Information
Figure S1 Controls for NK cell activation, cytokine
secretion and natural cytotoxicity. (A) FACS analysis of
surface CD69 and intracellular IFN-c expression in CD49b
+ cells
in the presence of spore-stimulated BMDMs. NK cells were gated
by their light scattering properties -forward (FSC) and side (SSC)
scatter- that distinguished them from the macrophages (left
panels), then dead cells were excluded along the FL4 channel
through staining with LIVE/DEAD Fixable Dead Cell Stain Kit
(Invitrogen). Isotype-matched controls Abs were used for each
staining combination (see Materials and Methods). (B) Effect of
NK Cell- B. anthracis Crosstalk
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IFN-c production by splenocytes. (C) Cell viability of splenocytes
18 h after incubation with PA+LF, or PA alone, LF alone
compared with untreated splenocytes, as assessed by Live/Dead
staining. (D) Absence of effect on the elimination of MHC class I-
deficient b2m2/2 splenocytes for the control groups receiving PA
alone, EF alone or LF alone (see Figure 5B).
(TIF)
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